Literature DB >> 25394640

Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia.

Juhi Shukla1, Scott W Walsh2.   

Abstract

Obesity is a risk factor for preeclampsia, but the reason for this risk is unknown. Neutrophils infiltrate into systemic blood vessels of both obese and preeclamptic women. Neutrophils are a major source of myeloperoxidase (MPO), which is associated with hypertension. We tested the hypothesis that systemic vasculature of both obese and preeclamptic women will have a significant presence of MPO as a result of neutrophil infiltration. We found that immunohistochemical staining of MPO was significantly greater in subcutaneous fat blood vessels of obese women than overweight women, which was significantly greater than normal weight women. Expression of MPO was significantly greater in maternal blood vessels of preeclamptic women than normal pregnant or normal nonpregnant women. In general, when vessels of overweight or normal pregnant women were stained it was primarily for leukocytes in the lumen and not infiltrated into the vessel. In contrast, in obese and preeclamptic women staining was present for leukocytes in the lumen, flattened, and adhered to the endothelium and infiltrated into the vessel wall. There was also extensive diffuse staining for MPO in vessels of obese and preeclamptic women. In conclusion, both obese and preeclamptic women have increased presence of MPO in systemic vasculature as a result of neutrophil infiltration. We speculate that obese women may be at risk of preeclampsia because their vasculature is already prone to hypertension.
© The Author(s) 2014.

Entities:  

Keywords:  hypertension; myeloperoxidase; neutrophils; obesity; preeclampsia

Mesh:

Substances:

Year:  2014        PMID: 25394640      PMCID: PMC4352145          DOI: 10.1177/1933719114557899

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  38 in total

1.  Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy.

Authors:  S Lurie; E Frenkel; Y Tuvbin
Journal:  Gynecol Obstet Invest       Date:  1998       Impact factor: 2.031

2.  Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: protective effect of antioxidants.

Authors:  J A Wang; E Z Zhen; Z Z Guo; Y C Lu
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

Review 3.  Myeloperoxidase: friend and foe.

Authors:  Seymour J Klebanoff
Journal:  J Leukoc Biol       Date:  2005-02-02       Impact factor: 4.962

4.  Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group.

Authors:  B M Sibai; M Ewell; R J Levine; M A Klebanoff; J Esterlitz; P M Catalano; R L Goldenberg; G Joffe
Journal:  Am J Obstet Gynecol       Date:  1997-11       Impact factor: 8.661

5.  Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

Authors:  G P Sacks; K Studena; K Sargent; C W Redman
Journal:  Am J Obstet Gynecol       Date:  1998-07       Impact factor: 8.661

6.  Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane.

Authors:  S W Walsh; Y Wang; R Jesse
Journal:  Am J Obstet Gynecol       Date:  1993-10       Impact factor: 8.661

7.  Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  B M Sibai; T Gordon; E Thom; S N Caritis; M Klebanoff; D McNellis; R H Paul
Journal:  Am J Obstet Gynecol       Date:  1995-02       Impact factor: 8.661

8.  Risk factors for severe preeclampsia.

Authors:  J L Stone; C J Lockwood; G S Berkowitz; M Alvarez; R Lapinski; R L Berkowitz
Journal:  Obstet Gynecol       Date:  1994-03       Impact factor: 7.661

Review 9.  Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia.

Authors:  S W Walsh
Journal:  Semin Reprod Endocrinol       Date:  1998

10.  Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults.

Authors:  Ashley E Walker; Sara Marian Seibert; Anthony J Donato; Gary L Pierce; Douglas R Seals
Journal:  Hypertension       Date:  2010-01-04       Impact factor: 10.190

View more
  12 in total

1.  Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1.

Authors:  William H Nugent; Nikita Mishra; Jerome F Strauss; Scott W Walsh
Journal:  Reprod Sci       Date:  2015-10-04       Impact factor: 3.060

2.  Upregulation of cathepsin C expression contributes to endothelial chymase activation in preeclampsia.

Authors:  Yang Gu; David F Lewis; J Steven Alexander; Yuping Wang
Journal:  Hypertens Res       Date:  2017-09-07       Impact factor: 3.872

Review 3.  Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.

Authors:  Frank T Spradley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-30       Impact factor: 3.619

Review 4.  Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?

Authors:  Scott W Walsh; Jerome F Strauss
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

5.  Effect of Preeclampsia on Ultrastructure of Thyroid Gland, Hepatic Type 1 Iodothyronine Deiodinase, and Thyroid Hormone Levels in Rats.

Authors:  Yunlu Liu; Zhuping Xu; Yanqin Li; Wenyan Jiang; Ming Lan; Xiaojuan Xie; Yang Wang
Journal:  Biomed Res Int       Date:  2021-04-20       Impact factor: 3.411

6.  Neutrophil Depletion Attenuates Placental Ischemia-Induced Hypertension in the Rat.

Authors:  Jean F Regal; Kathryn E Lillegard; Ashley J Bauer; Barbara J Elmquist; Alex C Loeks-Johnson; Jeffrey S Gilbert
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

Review 7.  The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta.

Authors:  Scott W Walsh; Jerome F Strauss
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

Review 8.  Immune Mechanisms Linking Obesity and Preeclampsia.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Biomolecules       Date:  2015-11-12

9.  Myeloperoxidase is not a good biomarker for preeclampsia prediction.

Authors:  L Rocha-Penha; H Bettiol; M A Barbieri; V C Cardoso; R C Cavalli; V C Sandrim
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

10.  Early-pregnancy transcriptome signatures of preeclampsia: from peripheral blood to placenta.

Authors:  Aishwarya P Yadama; Enrico Maiorino; Vincent J Carey; Thomas F McElrath; Augusto A Litonjua; Joseph Loscalzo; Scott T Weiss; Hooman Mirzakhani
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.